Insomnia Therapeutics Market to grow by USD 1 billion from 2022-2027 | North America to account for 60% of market growth - Technavio

Source :: PR Newswire. November 27, 2023
Publication Year :: 2023
Abstract: NEW YORK, Nov. 27, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/report/insomnia-therapeutics-market-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk48_2023_016_rep&utm_content=IRTNTR76428 size is expected to grow byUSD 1 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

Subjects :: Astellas Pharma Inc. -- Forecasts and trends
Merck & Company Inc. -- Forecasts and trends
Takeda Pharmaceutical Company Ltd. -- Forecasts and trends
Aurobindo Pharma Ltd. -- Forecasts and trends
Pfizer Inc. -- Forecasts and trends
Viatris Inc. -- Forecasts and trends
Mallinckrodt PLC -- Forecasts and trends
Sun Pharmaceutical Industries Ltd. -- Forecasts and trends
Eisai Company Ltd. -- Forecasts and trends
Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends
Sanofi S.A. -- Forecasts and trends
Insomnia -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Market trend/market analysis
Business
News, opinion and commentary

Tools